Mengjiao Sun
Lanzhou, 730030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Correction: Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response.
Journal: Journal of inflammation (London, England)
Published: November 11, 2024
Curcumin ameliorates astrocyte inflammation through AXL in cuprizone-induced mice.
Journal: Toxicology and applied pharmacology
Published: August 20, 2024
Novel anti-inflammatory compounds that alleviate experimental autoimmune encephalomyelitis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: June 23, 2024
Perturbed microbial ecology in neuromyelitis optica spectrum disorder: Evidence from the gut microbiome and fecal metabolome.
Journal: Multiple sclerosis and related disorders
Published: October 27, 2023
Dabrafenib mitigates the neuroinflammation caused by ferroptosis in experimental autoimmune encephalomyelitis by up regulating Axl receptor.
Journal: European journal of pharmacology
Published: October 20, 2023
Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response.
Journal: Journal of inflammation (London, England)
Published: May 09, 2023
Curcumin protects mice with myasthenia gravis by regulating the gut microbiota, short-chain fatty acids, and the Th17/Treg balance.
Journal: Heliyon
Published: March 28, 2023
MicroRNA‑155‑5p affects regulatory T cell activation and immunosuppressive function by targeting BCL10 in myasthenia gravis.
Journal: Experimental and therapeutic medicine
Published: February 13, 2023
AXL-Induced Autophagy mitigates experimental autoimmune encephalomyelitis by suppressing microglial inflammation via the PI3K/AKT/mTOR signaling pathway.
Journal: Molecular immunology
Published: December 30, 2022
Outcome of COVID-19 Infection in Patients With Multiple Sclerosis Who Received Disease-Modifying Therapies: A Systematic Review and Meta-Analysis.
Journal: Journal of clinical neurology (Seoul, Korea)
Published: September 14, 2022
Prognostic value of neurofilament light chain in natalizumab therapy for different phases of multiple sclerosis: A systematic review and meta-analysis.
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: March 18, 2022
Curcumin regulates anti-inflammatory responses by AXL/JAK2/STAT3 signaling pathway in experimental autoimmune encephalomyelitis.
Journal: Neuroscience letters
Published: February 13, 2022
Last Updated: 09/26/2026